Health Ministry blasted over decision to allow fetus sex selection [Israel]
By Haaretz,
Haaretz
| 05. 20. 2005
The Health Ministry has been sharply criticized for its decision to allow parents to choose their baby's sex in cases defined as "exceptional."
Commissioner for Future Generations Shlomo Shoham, a retired judge, said yesterday that "providing the option of choosing the sex of a fetus is sliding down a slippery slope," and "another step on the road to severe moral deterioration."
Shoham intends to use his authority to recommend that the Knesset pass a law banning the possibility of choosing the sex of a fetus, except when there is an established mortal danger.
MK Roman Bronfman (Yahad) asked the chairman of the Knesset Welfare and Health Committee to convene a meeting as soon as possible to address the issue. "This is an extremely serious ethical issue and the committee must discuss the limits of human intervention in the rules of nature," Bronfman said.
The Health Ministry decision created for the first time an official opening for using technology to select a baby's sex for nonmedical reasons. Such use of technology, Shoham said, "is banned in many countries in the world...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...